Connect Biopharma (CNTB) Institutional Ownership $0.84 +0.02 (+1.87%) As of 12:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)CurrentInstitutional OwnershipPercentage58.72%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$445.50KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$98.26K Get CNTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNTB Institutional Buying and Selling by Quarter Connect Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025Renaissance Technologies LLC134,697$186K0.0%-23.2%0.244% 2/3/2025 Callan Capital LLC80,000$110K0.0%+91.3%0.145% 1/27/2025Choreo LLC160,867$204K0.0%N/A0.291% 1/24/2025 Catalina Capital Group LLC47,867$66K0.0%N/A0.087% 11/5/2024BML Capital Management LLC2,093,232$3.01M1.8%+2.4%3.789% 8/9/2024Renaissance Technologies LLC212,300$323K0.0%-11.5%0.385% 7/17/2024 Keudell Morrison Wealth Management32,200$49K0.0%+63.5%0.058% 5/7/2024 Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036% 1/30/2024BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743% 8/15/2023Kynam Capital Management LP535,005$603K0.1%-27.7%0.972% Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049% 8/16/2022DAFNA Capital Management LLC250,000$218K0.1%N/A0.454% 5/13/2022Kynam Capital Management LP227,759$688K0.2%N/A0.414% 2/22/2022DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174% 2/14/2022Altium Capital Management LP175,000$901K0.2%N/A0.304% 2/14/2022Deep Track Capital LP647,057$3.33M0.2%N/A1.125% 2/11/2022Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044% 11/16/2021Janus Henderson Group PLC403,459$9.57M0.0%+3.1%0.702% 11/16/2021Wellington Management Group LLP1,145,177$27.37M0.0%-25.3%1.991% 11/12/2021Vident Investment Advisory LLC10,851$263K0.0%N/A0.019% 11/9/2021BlackRock Inc.2,450,065$59.37M0.0%-0.3%4.261% 11/5/2021Daiwa Securities Group Inc.6,069$147K0.0%N/A0.011% 8/17/2021Millennium Management LLC42,856$837K0.0%+286.1%0.075% 8/17/2021Old Well Partners LLC122,431$2.39M1.1%N/A0.213% 8/16/2021RA Capital Management L.P.6,991,003$136.53M2.2%+133.7%12.157% 8/16/2021Federated Hermes Inc.12,000$234K0.0%-70.0%0.021% 8/13/2021FMR LLC3,925,836$76.67M0.0%+23.3%6.827% 8/11/2021BlackRock Inc.2,458,132$48.01M0.0%+0.3%4.275% 8/10/2021Citigroup Inc.1,413$28K0.0%N/A0.002% 5/19/2021Logos Global Management LP150,000$2.78M0.3%N/A0.261% 5/19/2021Octagon Capital Advisors LP373,492$6.91M2.6%N/A0.650% 5/18/2021Millennium Management LLC11,099$205K0.0%N/A0.019% 5/18/2021Zimmer Partners LP10,000$185K0.0%N/A0.017% 5/18/2021RA Capital Management L.P.2,991,208$55.34M0.8%N/A5.202% 5/18/2021State of Wisconsin Investment Board100,272$1.86M0.0%N/A0.174% 5/18/2021Alyeska Investment Group L.P.50,000$925K0.0%N/A0.087% 5/18/2021Boxer Capital LLC2,081,323$38.50M1.3%N/A3.619% 5/18/2021Cormorant Asset Management LP1,000,000$18.50M0.4%N/A1.739% How to invest in Elon Musk’s Optimus before its launch (Ad)Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.Get all the information here.5/18/2021Citadel Advisors LLC245,191$4.54M0.0%N/A0.426% 5/17/2021Point72 Hong Kong Ltd10,426$193K0.0%N/A0.018% 5/17/2021Rock Springs Capital Management LP119,114$2.20M0.0%N/A0.207% 5/17/2021DAFNA Capital Management LLC8,000$148K0.0%N/A0.014% 5/17/2021Janus Henderson Group PLC475,000$8.70M0.0%N/A0.826% 5/17/2021Pinz Capital Management LP43,100$797K0.2%N/A0.075% 5/17/2021Sphera Funds Management LTD.50,000$925K0.1%N/A0.087% 5/14/2021RTW Investments LP450,000$8.33M0.1%N/A0.783% 5/14/2021Monashee Investment Management LLC110,000$2.04M0.3%N/A0.191% 5/13/2021Federated Hermes Inc.40,000$740K0.0%N/A0.070% (Data available from 1/1/2016 forward) CNTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNTB shares? During the previous two years, the following institutional investors and hedge funds held shares of Connect Biopharma shares: BML Capital Management LLC ($3.01M), Kynam Capital Management LP ($603K), Choreo LLC ($204K), Renaissance Technologies LLC ($186K), Callan Capital LLC ($110K), and Catalina Capital Group LLC ($66K), and Keudell Morrison Wealth Management ($49K).Learn more on CNTB's institutional investors. What percentage of Connect Biopharma stock is owned by institutional investors? 58.72% of Connect Biopharma stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings. Which institutional investors have been buying Connect Biopharma stock? The following institutional investors have purchased Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($2.11M), Choreo LLC ($160.87K), Catalina Capital Group LLC ($47.87K), Callan Capital LLC ($38.18K), and Keudell Morrison Wealth Management ($21K). How much institutional buying is happening at Connect Biopharma? Institutional investors have bought a total of 2,379,333 shares in the last 24 months. This purchase volume represents approximately $2.88M in transactions. Which Connect Biopharma major shareholders have been selling company stock? The following institutional investors have sold Connect Biopharma stock in the last 24 months: Kynam Capital Management LP ($204.64K), and Renaissance Technologies LLC ($68.40K). How much institutional selling is happening at Connect Biopharma? Institutional investors have sold a total of 273,047 shares in the last 24 months. This volume of shares sold represents approximately $329.51K in transactions. Related Companies INBX Institutional Ownership ACTU Institutional Ownership IPHA Institutional Ownership CYBN Institutional Ownership LFVN Institutional Ownership NBTX Institutional Ownership MOLN Institutional Ownership DMAC Institutional Ownership TNGX Institutional Ownership ACIU Institutional Ownership This page (NASDAQ:CNTB) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNTB Stock Free CNTB Stock Alerts